Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells

被引:67
作者
Reis, DJ [1 ]
Yang, XC [1 ]
Milner, TA [1 ]
机构
[1] Cornell Univ Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY 10021 USA
关键词
4-aminobutyl guanidine; excitatory-type terminals; electron microscopy;
D O I
10.1016/S0304-3940(98)00466-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We examined the cellular and subcellular localization of agmatine in the hippocampal CA1 region by immunocytochemistry. By light microscopy, agmatine-like immunoreactivity (agmatine-LI) was found primarily in the perikarya and dendritic profiles of pyramidal cells and in punctate processes preponderantly in stratum radiatum. Electron microscopy revealed that agmatine-LI was cytoplasmic and concentrated in 'clusters' associated with mitochondria and tubular vesicles. In stratum radiatum, agmatine-LI was primarily in axons and axon terminals associated with small, synaptic vesicles. The terminals almost exclusively formed asymmetric synapses on the spines of dendrites, many of which originated from pyramidal cells. Some agmatine-LI also was present in shafts and spines of pyramidal cell dendrites and in astrocytic processes. The results demonstrate that agmatine in the hippocampus is found primarily in terminals forming excitatory (asymmetric) synapses on pyramidal cells, some of which contain agmatine-LI. These findings further implicate agmatine as an endogenous neurotransmitter which may be co-stored with L-glutamate and may act in part in the rat hippocampus as a blocker of the N-methyl-D-aspartate receptor and nitric oxide synthase. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:185 / 188
页数:4
相关论文
共 20 条
[1]   Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection [J].
Feng, YZ ;
Halaris, AE ;
Piletz, JE .
JOURNAL OF CHROMATOGRAPHY B, 1997, 691 (02) :277-286
[2]   Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine [J].
Galea, E ;
Regunathan, S ;
Eliopoulos, V ;
Feinstein, DL ;
Reis, DJ .
BIOCHEMICAL JOURNAL, 1996, 316 :247-249
[3]   I-2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease [J].
GargalidisMoudanos, C ;
Pizzinat, N ;
JavoyAgid, F ;
Remaury, A ;
Parini, A .
NEUROCHEMISTRY INTERNATIONAL, 1997, 30 (01) :31-36
[4]   Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery [J].
Gonzalez, C ;
Regunathan, S ;
Reis, DJ ;
Estrada, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (04) :677-684
[5]   AGMATINE, A NOVEL HYPOTHALAMIC AMINE, STIMULATES PITUITARY LUTEINIZING-HORMONE RELEASE IN-VIVO AND HYPOTHALAMIC LUTEINIZING-HORMONE-RELEASING HORMONE-RELEASE IN-VITRO [J].
KALRA, SP ;
PEARSON, E ;
SAHU, A ;
KALRA, PS .
NEUROSCIENCE LETTERS, 1995, 194 (03) :165-168
[6]   AGMATINE - AN ENDOGENOUS CLONIDINE-DISPLACING SUBSTANCE IN THE BRAIN [J].
LI, G ;
REGUNATHAN, S ;
BARROW, CJ ;
ESHRAGHI, J ;
COOPER, R ;
REIS, DJ .
SCIENCE, 1994, 263 (5149) :966-969
[7]  
Malen PL, 1997, J NEUROSCI, V17, P2645
[8]  
Milner TA, 1998, J COMP NEUROL, V395, P310
[9]   Regional localization of agmatine in the rat brain: an immunocytochemical study [J].
Otake, K ;
Ruggiero, DA ;
Regunathan, S ;
Wang, H ;
Milner, TA ;
Reis, DJ .
BRAIN RESEARCH, 1998, 787 (01) :1-14
[10]  
PILETZ JE, 1995, J PHARMACOL EXP THER, V272, P581